241 related articles for article (PubMed ID: 3126369)
1. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
[TBL] [Abstract][Full Text] [Related]
2. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
Lasky JL; Thorbecke GJ
Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
[TBL] [Abstract][Full Text] [Related]
3. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
5. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
[TBL] [Abstract][Full Text] [Related]
7. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assay.
Gordon J; Millsum MJ; Guy GR; Ledbetter JA
Eur J Immunol; 1987 Oct; 17(10):1535-8. PubMed ID: 3500063
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
Clutterbuck E; Shields JG; Gordon J; Smith SH; Boyd A; Callard RE; Campbell HD; Young IG; Sanderson CJ
Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
[TBL] [Abstract][Full Text] [Related]
13. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
14. Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia.
Touw I; Groot-Loonen J; Broeders L; van Agthoven T; Hählen K; Hagemeijer A; Löwenberg B
Leukemia; 1989 May; 3(5):356-62. PubMed ID: 2497281
[TBL] [Abstract][Full Text] [Related]
15. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response.
Karray S; Delfraissy JF; Merle-Beral H; Wallon C; Debre P; Galanaud P
J Immunol; 1988 Feb; 140(3):774-8. PubMed ID: 3257503
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
17. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
19. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]